Involvement of Gut Microbial Metabolites Derived from Diet on Host Energy Homeostasis

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 May 28

PMID 35628369

Authors

Akari Nishida

Yuna Ando

Ikuo Kimura

Junki Miyamoto

Affiliations

Soon will be listed here.

Abstract

Due to the excess energy intake, which is a result of a high fat and high carbohydrate diet, dysfunction of energy balance leads to metabolic disorders such as obesity and type II diabetes mellitus (T2DM). Since obesity can be a risk factor for various diseases, including T2DM, hypertension, hyperlipidemia, and metabolic syndrome, novel prevention and treatment are expected. Moreover, host diseases linked to metabolic disorders are associated with changes in gut microbiota profile. Gut microbiota is affected by diet, and nutrients are used as substrates by gut microbiota for produced metabolites, such as short-chain and long-chain fatty acids, that may modulate host energy homeostasis. These free fatty acids are not only essential energy sources but also signaling molecules via G-protein coupled receptors (GPCRs). Some GPCRs are critical for metabolic functions, such as hormone secretion and immune function in various types of cells and tissues and contribute to energy homeostasis. The current studies have shown that GPCRs for gut microbial metabolites improved host energy homeostasis and systemic metabolic disorders. Here, we will review the association between diet, gut microbiota, and host energy homeostasis.

Citing Articles

Enteric Delayed-Release Granules Loading Dendrobine Ameliorates Hyperlipidemia in Mice by Regulating Intestinal Flora Composition.

Song S, Yang L, Chen T, Xiong Y Pharmaceutics. 2024; 16(11).

PMID: 39598605 PMC: 11597677. DOI: 10.3390/pharmaceutics16111483.

Importance of diet and intestinal microbiota in the prevention of colorectal cancer - colonoscopy early screening diagnosis.

Jovandaric M World J Gastrointest Oncol. 2024; 16(8):3428-3435.

PMID: 39171174 PMC: 11334020. DOI: 10.4251/wjgo.v16.i8.3428.

Lactiplantibacillus argentoratensis AGMB00912 alleviates salmonellosis and modulates gut microbiota in weaned piglets: a pilot study.

Yoon K, Lee H, Yeom S, Kim S, Park J, Song B Sci Rep. 2024; 14(1):15466.

PMID: 38965336 PMC: 11224356. DOI: 10.1038/s41598-024-66092-z.

Gut Dysbiosis Shaped by Cocoa Butter-Based Sucrose-Free HFD Leads to Steatohepatitis, and Insulin Resistance in Mice.

Kochumon S, Malik M, Sindhu S, Arefanian H, Jacob T, Bahman F Nutrients. 2024; 16(12).

PMID: 38931284 PMC: 11207001. DOI: 10.3390/nu16121929.

Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease.

Mogna-Pelaez P, Romo-Hualde A, Riezu-Boj J, Milagro F, Munoz-Prieto D, Herrero J J Physiol Biochem. 2023; 80(3):639-653.

PMID: 37996653 PMC: 11502611. DOI: 10.1007/s13105-023-00998-6.

References

Wan Y, Wang F, Yuan J, Li J, Jiang D, Zhang J . Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut. 2019; 68(8):1417-1429. DOI: 10.1136/gutjnl-2018-317609. View

Nagasumi K, Esaki R, Iwachidow K, Yasuhara Y, Ogi K, Tanaka H . Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes. 2009; 58(5):1067-76. PMC: 2671040. DOI: 10.2337/db08-1233. View

Jiang C, Xie C, Li F, Zhang L, Nichols R, Krausz K . Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest. 2014; 125(1):386-402. PMC: 4382255. DOI: 10.1172/JCI76738. View

Samuel B, Shaito A, Motoike T, Rey F, Backhed F, Manchester J . Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A. 2008; 105(43):16767-72. PMC: 2569967. DOI: 10.1073/pnas.0808567105. View

Newgard C . Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012; 15(5):606-14. PMC: 3695706. DOI: 10.1016/j.cmet.2012.01.024. View

Ridaura V, Faith J, Rey F, Cheng J, Duncan A, Kau A . Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341(6150):1241214. PMC: 3829625. DOI: 10.1126/science.1241214. View

Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L . A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2016; 23(1):107-113. DOI: 10.1038/nm.4236. View

Russell D . The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003; 72:137-74. DOI: 10.1146/annurev.biochem.72.121801.161712. View

Jandhyala S, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy D . Role of the normal gut microbiota. World J Gastroenterol. 2015; 21(29):8787-803. PMC: 4528021. DOI: 10.3748/wjg.v21.i29.8787. View

10.

Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

11.

Sayin S, Wahlstrom A, Felin J, Jantti S, Marschall H, Bamberg K . Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013; 17(2):225-35. DOI: 10.1016/j.cmet.2013.01.003. View

12.

Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen J . Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology. 2008; 149(9):4519-26. DOI: 10.1210/en.2008-0059. View

13.

Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T . The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013; 4:1829. PMC: 3674247. DOI: 10.1038/ncomms2852. View

14.

Barker D, WINTER P, Osmond C, Margetts B, Simmonds S . Weight in infancy and death from ischaemic heart disease. Lancet. 1989; 2(8663):577-80. DOI: 10.1016/s0140-6736(89)90710-1. View

15.

Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz A . Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017; 66(8):1414-1427. PMC: 5940336. DOI: 10.1136/gutjnl-2016-313099. View

16.

Sundstrom L, Myhre S, Sundqvist M, Ahnmark A, McCoull W, Raubo P . The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1. PLoS One. 2017; 12(12):e0189060. PMC: 5716539. DOI: 10.1371/journal.pone.0189060. View

17.

Tolhurst G, Heffron H, Lam Y, Parker H, Habib A, Diakogiannaki E . Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2011; 61(2):364-71. PMC: 3266401. DOI: 10.2337/db11-1019. View

18.

Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L . Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 2012; 483(7389):350-4. DOI: 10.1038/nature10798. View

19.

Franks P, McCarthy M . Exposing the exposures responsible for type 2 diabetes and obesity. Science. 2016; 354(6308):69-73. DOI: 10.1126/science.aaf5094. View

20.

Backhed F, Ding H, Wang T, Hooper L, Koh G, Nagy A . The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101(44):15718-23. PMC: 524219. DOI: 10.1073/pnas.0407076101. View